Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000018

Chief Scientific Officer sold 93,295 shares at an average $33.64 ($3,138,273)

  • Chief Scientific Officer acquired 93,295 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-12 Exercise or conversion : show line 1 in the form +36,705 $26.49 $972,315 269,255 D
2021-07-12 Sale : show line 2 in the form −36,705 $33.55 $1,231,431 232,550 D
2021-07-12 Exercise or conversion : show line 3 in the form +13,295 $26.49 $352,185 245,845 D
2021-07-12 Sale : show line 4 in the form −13,295 $33.55 $446,075 232,550 D
2021-07-13 Exercise or conversion : show line 5 in the form +3,295 $26.49 $87,285 235,845 D
2021-07-13 Sale : show line 6 in the form −3,295 $33.69 $111,012 232,550 D
2021-07-13 Exercise or conversion : show line 7 in the form +40,000 $26.49 $1,059,600 272,550 D
2021-07-13 Sale : show line 8 in the form −40,000 $33.74 $1,349,756 232,550 D
Open-market sales · 93,295 sh · avg $33.64 · $3,138,273

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-07-12 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −36,705 72,815 D
2021-07-12 Exercise or conversion : show line 10 in the form Non-Qualified Stock Option (right to buy) −13,295 59,520 D
2021-07-13 Exercise or conversion : show line 11 in the form Non-Qualified Stock Option (right to buy) −3,295 56,225 D
2021-07-13 Exercise or conversion : show line 12 in the form Non-Qualified Stock Option (right to buy) −40,000 16,225 D
Loading xslF345X03/edgardoc.xml…